-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanoform Finland Partners With CDMO for Biologics Manufacturing

MT Newswires·11/17/2026 01:37:36
Listen to the news
01:37 AM EST, 11/17/2026 (MT Newswires) -- Nanoform Finland (NANOFH.HE) partnered with a contract development and manufacturing organization, or CDMO, for the aseptic manufacturing of ultra-high concentration biologics. Under the deal, the partner will implement the medicine performance-enhancing company's biologics technology at its existing aseptic manufacturing facility in Germany, according to a Tuesday release. The partners are targeting good manufacturing practice readiness in the second half of 2027, which will be followed by a planned first customer clinical trial of a subcutaneous ultra-high-concentration suspension biologic product.